This patient’s tumor was diagnosed as an anaplastic thyroid carcinoma (ATC) and contained a BRAF V600E mutation, in addition to NF2 and TP53 mutations. This evidence concerns the gene NF2 and thyroid gland undifferentiated (anaplastic) carcinoma.